IMNP Symposium at ACUTE LEUKEMIAS XVI, Munich, Feb 2017

Biology and Treatment Strategies
Munich, Germany – February 19-22, 2017
Immune Pharmaceuticals Symposium

Professor Kristoffer Hellstrand (University of Gothenburg) Presents the Role of Cytotoxic T-Cells in Remission Maintenance with Ceplene/Proleukin Therapy in AML   


Professor Jacob Rowe (Shaare Zedek, Jeruslaem) Describes the Potential of Ceplene/Proleukin, the Only Clinically Proven Maintenance Therapy in AML

Download PDF